Beta Bionics, Inc.
(NASDAQ: BBNX)
Beta Bionics, Inc. is a commercial-stage medical device company. It engages in the design, development, and commercialization of solutions for insulin-requiring people with diabetes. The company was founded by Edward R. Damiano on October 21, 2015 and is headquartered in Irvine, CA.
16.890
+1.590
(+10.39%)
Range
15.220 - 17.000
(11.70%)
Open
15.310
Previous Close
15.300
Bid Price
-
Bid Volume
-
Ask Price
-
Ask Volume
-
Volume
753,041
Value
-
Remark
View All Events
No Post Available
Please login to view stock data and analysis